JPRN-UMIN000011534
Completed
Phase 2
Phase II study of nab-paclitaxel and carboplatin for elderly patients with non-small cell lung cancer. (KRSG1303) - Phase II study of nab-paclitaxel and carboplatin for elderly patients with non-small cell lung cancer. (KRSG1303)
Kanto respiratory disease study group0 sites32 target enrollmentSeptember 1, 2013
Conditionson-small cell lung cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- on-small cell lung cancer
- Sponsor
- Kanto respiratory disease study group
- Enrollment
- 32
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This trial stopped because the targeted number of cases cannot be achieved.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with Symptomatic brain metastasis 2\) Patients have only non\-measurable lesion 3\) Patients with radiotherapy for cancer within 4 weeks 4\) Patients with interstitial pneumonia 5\) Patients with Serious complications (renal dysfunction, liver dysfunction, cardiac diseases, uncontrolled hypertension or diabetes) 6\) Patients with other Serious complications 7\) Judged ineligible based on physicians' decision
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Phase I study on the feasibility of Nedaplatin plus S-1 combination therapy for squamous cell lung cancer.JPRN-UMIN000009993Fukuoka University Hospital18
Completed
Phase 2
A phase II study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinomagastric cancerJPRN-UMIN000003201Study group of multi-modality therapy for gastric cancer5
Completed
Phase 2
Phase II trial of neoadjuvant chemotherapy for unresectable liver metastasis of colorectal cancerColorectal cancer patients with unresectable liver metastasisJPRN-UMIN000006994Surgery, Kyorin university hospital10
Completed
Not Applicable
Phase II study for efficacy and safety of nab-paclitaxel and carboplatin combination chemotherapy for Previously untreated advanced non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000010738Tokyo Metropolitan Cancer and Infection diseases Center Komagome Hospital38
Completed
Phase 2
A phase II clinical trial of Carbon-ion therapy for patients with bone and soft tissue sarcomas not suited for surgical resectioBone and soft tissue tumorJPRN-UMIN000021557Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization